The Trump Administration’s weakening of regulatory benefit-cost analysis vests unequal power in executive review.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback